These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 27704622)

  • 21. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
    Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
    Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
    Ray A; Dittel BN
    Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microbiota in inflammatory bowel disease in different age groups.
    Cucchiara S; Iebba V; Conte MP; Schippa S
    Dig Dis; 2009; 27(3):252-8. PubMed ID: 19786749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
    Fritsch J; Abreu MT
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Human Gut Microbiota.
    Harmsen HJ; de Goffau MC
    Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
    Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
    Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
    Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
    Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput sequencing provides insights into oral microbiota dysbiosis in association with inflammatory bowel disease.
    Qi Y; Zang SQ; Wei J; Yu HC; Yang Z; Wu HM; Kang Y; Tao H; Yang MF; Jin L; Zen K; Wang FY
    Genomics; 2021 Jan; 113(1 Pt 2):664-676. PubMed ID: 33010388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
    Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
    Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Sundin J; Öhman L; Simrén M
    Psychosom Med; 2017 Oct; 79(8):857-867. PubMed ID: 28422780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease.
    Andoh A; Benno Y; Kanauchi O; Fujiyama Y
    Curr Pharm Des; 2009; 15(18):2066-73. PubMed ID: 19519444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota and IBD: Current knowledge and future perspectives.
    Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A
    Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oral-gut microbiome axis in inflammatory bowel disease: from inside to insight.
    Wang A; Zhai Z; Ding Y; Wei J; Wei Z; Cao H
    Front Immunol; 2024; 15():1430001. PubMed ID: 39131163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
    Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
    Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.
    Frank DN; St Amand AL; Feldman RA; Boedeker EC; Harpaz N; Pace NR
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13780-5. PubMed ID: 17699621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.